Sort by
Immuron Engages LifeSci Capital
Emerging Growth Conference Presentation
Immuron Updates At-The-Market Funding Facility
Immuron FY27 Sales Update
CEO to present at Emerging Growth Conference
Notice of Annual General Meeting and Proxy Form
Travelan Phase 2 Study Results Published
Change in substantial holding
Appendix 4G and Corporate Governance Statement
Annual Report
| Date | Headline |
|---|---|
10 Nov 2026 | Immuron Engages LifeSci Capital |
28 Oct 2026 | Emerging Growth Conference Presentation |
27 Oct 2026 | Immuron Updates At-The-Market Funding Facility |
27 Oct 2026 | Immuron FY27 Sales Update |
22 Oct 2026 | CEO to present at Emerging Growth Conference |
16 Oct 2026 | Notice of Annual General Meeting and Proxy Form |
13 Oct 2026 | Travelan Phase 2 Study Results Published |
1 Oct 2026 | Change in substantial holding |
24 Sep 2026 | Appendix 4G and Corporate Governance Statement |
24 Sep 2026 | Annual Report |